Single-arm: Blood pressure intervention for High Blood Pressure

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stanford University, Stanford, CAHigh Blood PressureMobile technology intervention - CombinationProduct
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trialwill explore a new system that uses mobile technology to help manage high blood pressure, connecting patients and clinicians.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 12 weeks

12 weeks
Blood pressure
Participant survey

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Single-arm: Blood pressure intervention
1 of 1

Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: Single-arm: Blood pressure intervention · No Placebo Group · N/A

Single-arm: Blood pressure intervention
CombinationProduct
Experimental Group · 1 Intervention: Mobile technology intervention · Intervention Types: CombinationProduct

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 weeks

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,186 Previous Clinical Trials
35,092,711 Total Patients Enrolled
American Heart AssociationOTHER
286 Previous Clinical Trials
5,824,188 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Are researchers actively signing up participants for this experiment?

"Per the clinicaltrials.gov listing, this medical experiment is currently seeking out patients. The trial was initially uploaded on March 31st 2021 and had its most recent adjustment made December 10th 2022." - Anonymous Online Contributor

Unverified Answer

What is the aggregate amount of participants involved in this clinical experiment?

"Affirmative, patient recruitment for this medical study is ongoing. Initially posted on March 31st 2021 and updated December 10th 2022, the trial requires 50 individuals to be enrolled at a single site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.